About Us

VivoSense is an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensors

We are focused on healthcare research & delivery, clinical trials and patient wellness. Our hypothesis-driven framework provides analytical and clinical validation leading to FDA approval. Delivering novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials.

Our Mission

Advance Knowledge

We believe the study of human health in real-world, everyday environments is necessary to advance knowledge and discovery.

Advance Knowledge

Body-Worn Monitoring

We make this possible by providing customized body-worn monitoring and analysis solutions rooted in scientific foundations.

Body-Worn Monitoring

Accurate Data Analysis

We enable the world’s best researchers to obtain the highest quality, real-world data and analyze it appropriately and accurately.

Accurate Data Analysis

The VivoSense Story

The founding team at VivoSense met and worked together at VivoMetrics, Inc., which manufactured and commercialized one of the first multichannel wearable sensors called LifeShirt. Applications for the LifeShirt (purchased by adidas in 2008) platform include aerospace research, infant monitoring, drug and device clinical trials (e.g. cough monitoring), and media/commercial research. The LifeShirt platform was supported using an analysis software known as VivoLogic. VivoSense was created to become the second-generation version of VivoLogic which would service ALL commercially available wearable sensors, many of which were predicated on the LifeShirt sensor.

The creation of VivoSense software was initially funded with a $1M grant from the US Navy which required software for the interrogation of physiological sensors placed directly on-body. From inception copies of VivoSense software were sold to academic researchers and not for profit companies that continue to provide academic validation and peer-reviewed publications using the software. VivoSense has subsequently grown to service the pharmaceutical clinical trials industry using the software as the environment in which new digital biomarkers are created.

Meet the VivoSense Team

Dudley Tabakin

Dudley Tabakin, Chief Executive Officer
Connect on LinkedIn

Patrick Hankey, PhD.

Patrick Hankey, PhD., VP Business Development
Connect on LinkedIn

Thomas Leonard

Thomas Leonard, VP Sales
Connect on LinkedIn

Kate Lyden, PhD.

Kate Lyden, PhD., Chief Science Officer
Connect on LinkedIn

Doug McAllister

Doug McAllister, Chief Technology Officer
Connect on LinkedIn

Ralf- Hempfling

Ralf Hempfling, PhD., Chief Algorithm Officer
Connect on LinkedIn

Core Values

VivoSense - About Us
  • Better Outcome for Patients: VivoSense is committed to the development of better medicines and medical interventions for improved patient outcomes.
  • Scientific Integrity: Guided by scientific principles, applying leading-edge methodologies with accuracy, academic transparency within the regulated framework required by our industry.
  • Customer-Centric: VivoSense never tells the customer anything but the scientific truth, never promising what cannot be delivered.
  • Business Friendly: VivoSense values partnerships in business and is always a good corporate partner.
  • Diversity and Inclusion: VivoSense is committed to diversity and inclusion, where every voice is heard and the best-reasoned facts are those acted upon.
  • Environmental Responsibility: VivoSense strives for a minimal environmental impact, printing documents and traveling for business only when necessary.
  • Family Values: VivoSense recognizes the balance in work and family and provides for a flexible schedule, encouraging telecommuting whenever possible and minimizing the need for commuting at all times.